Skip to Main Content

Author Details

Sarah Chan
the Francis Crick Institute
2006
25
9
PMIDPaper TitleJournal TitlePublished Year
32063591Playing it Safe? Precaution, Risk, and Responsibility in Human Genome Editing.Perspect Biol Med2020
28541162Commentary: What Price Freedom?Camb Q Healthc Ethics2017
25516926A bioethics for all seasons.J Med Ethics2015
26632362Genome Editing Technologies and Human Germline Genetic Modification: The Hinxton Group Consensus Statement.Am J Bioeth2015
26560284CRISPR: A path through the thicket.Nature2015
24521329Hidden anthropocentrism and the "benefit of the doubt": problems with the "origins" approach to moral status.Am J Bioeth2014
23292095Beyond the is/ought divide: studying the nature of the bioethical enterprise.Health Care Anal2013
23684534Reply: Human germline genetic modification: scientific and bioethical perspectives.Arch Med Res2013
23072719Human germline genetic modification: scientific and bioethical perspectives.Arch Med Res2012
21325675Moral enhancement and pro-social behaviour.J Med Ethics2011
21676334Does a fish need a bicycle? Animals and evolution in the age of biotechnology.Camb Q Healthc Ethics2011
20025803Consequentialism without consequences: ethics and embryo research.Camb Q Healthc Ethics2010
21098659Moral behavior is not what it seems.Proc Natl Acad Sci U S A2010
20547688Patents in synthetic biology.BMJ2010
20434710The ethical and scientific case for phase 2C clinical trials.Lancet Oncol2010
18445091Free riders and pious sons--why science research remains obligatory.Bioethics2009
19880704Should we enhance animals?J Med Ethics2009
19567684More than cautionary tales: the role of fiction in bioethics.J Med Ethics2009
18234938Adam's fibroblast? The (pluri)potential of iPCs.J Med Ethics2008
18578030Humanity 2.0? Enhancement, evolution and the possible futures of humanity.EMBO Rep2008
18283288Enhancement is good for you!: understanding the ethics of genetic enhancement.Gene Ther2008
17845450Frozen embryos, genetic information and reproductive rights.Bioethics2007
16404360SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer.Br J Cancer2006
17078379The ethics of gene therapy.Curr Opin Mol Ther2006
17465790Cognitive regeneration or enhancement: the ethical issues.Regen Med2006
  • 1 - 25 of 25

Recommended Authors

Portland State University
Career Start Year 2017
Number of shared co-authors 1
Universite Laval
Career Start Year 2013
Number of shared co-authors 0
Universite de Montreal.
Career Start Year 2012
Number of shared co-authors 0
University of Potsdam
Career Start Year 2012
Number of shared co-authors 1
Institute on Ethics and Policy for Innovation, McMaster University
Career Start Year 2007
Number of shared co-authors 0
Research Ethics Program, 4University of California
Career Start Year 2005
Number of shared co-authors 0
New York University.
Career Start Year 2005
Number of shared co-authors 2
University of San Diego School of Law
Career Start Year 2004
Number of shared co-authors 0
The Hastings Center
Career Start Year 2002
Number of shared co-authors 1
Petrie-Flom Center for Health Law Policy, Harvard University
Career Start Year 2000
Number of shared co-authors 1
Department of Philosophy and Center for Bioethics, Wake Forest University
Career Start Year 2000
Number of shared co-authors 0
Center for Bioethics, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 2
Wyss Institute for Biologically Inspired Engineering, Harvard University
Career Start Year 1999
Number of shared co-authors 2
Stanford Center for Biomedical Ethics, Stanford University
Career Start Year 1998
Number of shared co-authors 0
University of Arkansas for Medical Sciences, College of Medicine
Career Start Year 1998
Number of shared co-authors 1
University of South Carolina
Career Start Year 1993
Number of shared co-authors 0
Career Start Year 1993
Number of shared co-authors 0
Berman Institute of Bioethics, Johns Hopkins University
Career Start Year 1991
Number of shared co-authors 3
The Center for Law and the Biosciences, Stanford University
Career Start Year 1989
Number of shared co-authors 4
University of Wisconsin-Madison/Nuclear Threat Initiative
Career Start Year 1987
Number of shared co-authors 2
Dalhousie University
Career Start Year 1987
Number of shared co-authors 1
Centre for Biomedical Ethics, National University of Singapore
Career Start Year 1987
Number of shared co-authors 6
American University of Sovereign Nations
Career Start Year 1986
Number of shared co-authors 0
Center for Ethics, Emory University
Career Start Year 1985
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1980
Number of shared co-authors 0
University of Arizona
Career Start Year 1978
Number of shared co-authors 0
Division of Medical Ethics, New York University Grossman School of Medicine
Career Start Year 1976
Number of shared co-authors 1
The Kennedy Institute of Ethics, Georgetown University
Career Start Year 1976
Number of shared co-authors 1
Gould School of Law & Keck School of Medicine, University of Southern California
Career Start Year 1973
Number of shared co-authors 0
Boston University School of Public Health.
Career Start Year 1973
Number of shared co-authors 0

Collaborators

University of Manchester
Co-authored papers 13
The Francis Crick Institute
Co-authored papers 2
University of Oxford.
Co-authored papers 2
Carlsberg Laboratory, Case Western Reserve University, Johns Hopkins Medicine, Johns Hopkins School of Medicine, Johns Hopkins School of Public Health, Johns Hopkins University, National Academy of Sciences, Pennsylvania State University, Presidential Commission for the Study of Bioethical Issues
Co-authored papers 2
University of California irvine
Co-authored papers 2
Johns Hopkins Berman Institute of Bioethics
Co-authored papers 2
University of Melbourne
Co-authored papers 2
The University of Manchester School of Social Sciences
Co-authored papers 1